Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    Tregs | Diabetes
Show Display Options
Rank Status Study
1 Active, not recruiting T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
2 Recruiting T1DM Immunotherapy Using Polyclonal Tregs + IL-2
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Treg+IL-2
3 Active, not recruiting Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin
4 Completed Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin (Proleukin)
5 Active, not recruiting Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Dose D1 of interleukin-2;   Drug: placebo;   Drug: Dose D2 of Interleukin-2;   Drug: Dose D3 of interleukin-2
6 Withdrawn Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA)
Condition: Autoimmune Diabetes
7 Recruiting Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)
Condition: Diabetes Mellitus
Interventions: Biological: CLBS03 Low Dose;   Biological: CLBS03 High Dose;   Biological: Placebo
8 Recruiting Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: rhIL-2;   Drug: Placebo
9 Completed Dose-effect Relationship of Low-dose IL-2 in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin
10 Recruiting Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
Conditions: Diabetes Mellitus;   Malignant Neoplasm
Interventions: Procedure: assessment of therapy complications;   Other: laboratory biomarker analysis
11 Recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
12 Unknown  The Role of Regulatory T Cell in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: blood drawing
13 Unknown  Study of Immune Response in Obesity and Type 2 Diabetes
Conditions: Obesity;   Type 2 Diabetes;   Healthy Volunteers
Intervention: Other: Blood samples
14 Active, not recruiting
Has Results
Reversing Type 1 Diabetes After it is Established
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globin (ATG);   Drug: Placebo;   Drug: Pegylated GCSF
15 Completed Stem Cell Educator Therapy in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Device: Stem Cell Educator
16 Completed Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Liraglutide;   Drug: Placebo;   Drug: Mixed Meal Tolerance Test with paracetamol
17 Completed Neulasta in Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Neulasta (Pegylated);   Drug: Placebo;   Dietary Supplement: Mixed Meal Tolerance Test (MMTT);   Other: Blood test;   Other: DNA Test
18 Completed Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Cholecalciferol
19 Recruiting The Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)
Condition: Type 1 Diabetes
Intervention: Other: Gluten-free diet
20 Not yet recruiting Diabetes Islet Preservation Immune Treatment
Conditions: Diabetes Mellitus, Type 1;   Hypoglycemia;   Autoimmune Diseases;   Diabetes Mellitus
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Placebo;   Drug: Pegylated GCSF;   Drug: Interleukin 2;   Drug: Etanercept;   Drug: Exenatide

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years